SAN ANTONIO — Several types of anti-obesity medications (AOMs), including glucagon-like peptide 1s (GLP-1s), are associated ...

AP file Share Fewer patients are seeking weight-loss surgeries as anti-obesity drugs have surged in popularity, a new study ...

The current pain caused by the high cost of the GLP-1 agonist anti-obesity drugs will pass. Prachi Patkee and other analysts ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

In our country, 4 out of 10 adults are overweight, and slightly more than 1 in 10 live with a condition of obesity, a chronic ...

The editorial director of British Vogue magazine on Wednesday said she was worried about the return of thin models, linking the trend to the widespread use of anti-obesity drugs.

Viking Therapeutics reported clinical trial data on Sunday, which excited some investors. Despite signs that Viking's ...

A new study examining a large sample of privately insured patients with obesity found that use of drugs such as Ozempic and Wegovy as anti-obesity medications more than doubled from 2022 to 2023.

This clinical trial is a randomized, double-blind study designed to enroll 120 patients across four treatment groups. The ...

Popular weight-loss drug Wegovy maker Novo Nordisk expects high demand and acceptance for its anti-obesity drug, when ...